Key statistics
As of last trade Simcere Pharmaceutical Group Ltd (S2P:FRA) traded at 0.745, -14.86% below its 52-week high of 0.875, set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.745 |
---|---|
High | 0.745 |
Low | 0.745 |
Bid | 0.745 |
Offer | 0.765 |
Previous close | 0.775 |
Average volume | 280.00 |
---|---|
Shares outstanding | 2.53bn |
Free float | 722.05m |
P/E (TTM) | -- |
Market cap | 16.47bn HKD |
EPS (TTM) | -0.4543 HKD |
Annual div (ADY) | 0.021 EUR |
---|---|
Annual div yield (ADY) | 2.70% |
Div ex-date | Jun 18 2024 |
Div pay-date | Jul 15 2024 |
Data delayed at least 15 minutes, as of Nov 13 2024 07:13 GMT.
More ▼
Press releases
- World Stroke Congress | TASTE-2 significantly reduces stroke disability
- TASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability
- Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
- Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor